Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
During sample collection an assessment as to whether an individual was affected with konzo was conducted following the WHOs 3 main criteria for diagnosis including evidence of (1) a visible symmetric spastic abnormality of gait while walking or running, (2) a history of onset of less than 1 week followed by a nonprogressive course in a formerly healthy person, and (3) bilaterally exaggerated knee or ankle jerks without signs of disease of the spine
Glutathione (GSH) belongs to the group of medications called antioxidants
A 10 mL vial at 500 mg/mL holds 5000 mg total ten 1 mL draws of 500 mg each
Peptide 20, a GIPR/GLP-1R/GCGR triagonist (phase 1 clinical trials completed) 18,19,20 with balanced potency at the three receptors, is evolved from a GLP-1R/GCGR dual agonist 21 through iterative sequence refinement and modification (Supplementary Fig
US$ 25.00
US$ 24.16
US$ 29.14
US$ 25.78
